Sydney doctor warns hundreds of AstraZeneca vaccines are refusing despite extremely low health risks

A doctor has revealed that there are still hundreds who are rejecting the AstraZeneca vaccine in one of Sydney’s biggest Covid-19 hotspots, despite very rare blood clotting disorders linked to the injection becoming easier to treat.

dr. Kean-Seng Lim runs a medical center in Mount Druitt, in the west of the city, and says recent news of two more deaths related to the injection has raised concerns about the ‘highly effective’ vaccine.

The Therapeutic Goods Administration said on Thursday that a 44-year-old man from Tasmania and a 48-year-old woman from Victoria had died after taking their first dose of the vaccine.

In all, there have been six deaths from the 6.1 million doses of the AstraZeneca shot administered in Australia since the introduction of the Covid-19 vaccine, according to the TGA.

Average Australians are more likely to die from getting Covid-19 than from a blood clot after taking the AstraZeneca vaccine, data has revealed.

Australians are more likely to die from getting Covid-19 than from a blood clot after taking AstraZeneca vaccine, data has revealed, but many are still waiting for a Pfizer vaccine (woman pictured gets Pfizer vaccine in Sydney)

dr.  Kean-Seng Lim runs a medical center in Mount Druitt, west of the city, and says recent news of two more deaths related to the injection has fueled fears over the 'highly effective' vaccine

dr. Kean-Seng Lim runs a medical center in Mount Druitt, west of the city, and says recent news of two more deaths related to the injection has fueled fears over the ‘highly effective’ vaccine

“Unfortunately, no matter what happens, there will always be complications from everything,” Dr. lim A current matter.

“The most important thing to say is that we learn quite quickly and we also need to assess the risks and benefits of everything we do.”

dr. Lim said when the AstraZeneca vaccine was first offered there was a great response at his medical clinic, but some residents 60 and older are now waiting to get the Pfizer shot.

He said 600 of his 3,600 patients were eligible for AstraZeneca, but a third of them “show concern” about getting the shot.

The doctor says every day he describes the risks for those not getting the vaccine compared to the risk of contracting the highly contagious Delta strain of the virus.

“I’d say I have to talk to patients half a dozen times a day about exactly that problem,” he said.

“What is we need to see what the probability is of the side effect of a vaccine versus what the probability is of getting coronavirus and of course what is the probability of death or hospitalization from the disease.

‘So it is a consideration that every individual has to make and ultimately it is a personal choice.’

He noted that despite there being an extremely low chance that those who received the vaccine had health complications, more turned to Pfizer.

“Right now, AstraZeneca seems to have gained a bit of a reputation as a second-rate vaccine,” he said.

So far, only two in 100,000 people who received their first dose of the AstraZeneca vaccine in Australia have developed TTS (queues pictured at Sydney Vaccination Centre)

So far, only two in 100,000 people who received their first dose of the AstraZeneca vaccine in Australia have developed TTS (queues pictured at Sydney Vaccination Centre)

‘While we know that in reality it is a very effective vaccine and that it works really well.

“However, because of the negative publicity, because of the different statements from health groups, we have a situation where more patients are willing to have the Pfizer vaccine than AstraZeneca and yes, if we could get more Pfizer, we would give them as soon as they do.” enter.’

The cause of both deaths announced on Thursday was reported as probable thrombosis with thrombocytopenia syndrome (TTS) – a rare but serious blood clotting disorder with low platelet counts.

TTTS is easy to diagnose, very treatable and much less fatal than originally thought.

What are the chances of getting a blood clot?

Number of people who get blood clots after AstraZeneca per 100,000 people:

18-29 years: 1.9

30-39 years: 1.6

40-49 years: 5.0

50-59 years: 2.7

60-69 years: 1.4

70-79 years: 1.8

80+ years: 1.9

Total: 2.3 (0.0023%)

Only three percent of people who get the clots die

Source: ATAGIA

Professor Huyen Tran, head of the Thrombosis and Hemostasis Department, said experts developed a much better understanding of the syndrome last month.

“It’s always the case that new conditions have a higher death rate in the beginning, but the actual death rate is much lower in the end,” Professor Tran said.

“We understand that this condition has a very different mechanism than all other forms of blood clots. Failure to understand this difference in the past may have led to confusion and hesitation about getting vaccinated.

“We are now in an extremely strong position to recognize it, diagnose it and most importantly treat it properly.”

So far, only two in every 100,000 people who received their first dose of the AstraZeneca vaccine in Australia have developed TTS.

And of those who developed the condition, only six of the six million who had the shot have died.

The birth control pill causes between 5 and 12 women per 10,000 clots, according to the Department of Health, but these warnings are largely ignored.

The risk of dying from a vaccine-related blood clot is one in a million, but the risk to die in a pedestrian accident is eight in a million and the probability of dying in a car accident is 28 in a million.

Meanwhile, the Covid-19 mortality rate in Australia it is 3.9 percent, or 39,000 in a million.

Pfizer remains the recommended Covid-19 vaccine for Australians under 60, as the extremely rare AstraZeneca-related blood clotting disorder is slightly more common in younger people.

But Australian adults under 60 can still have access to the AstraZeneca injection if they discuss the decision with their GP and give informed consent.

Prime Minister Scott Morrison has stepped up pressure on the Australian Technical Advisory Group on Immunization to reconsider that advice – arguing that the outbreaks in NSW, Victoria and South Australia are changing the equation.

Just under 15 percent of Australians over the age of 16 are fully vaccinated.

Government experts have created models (above) to show the risk of getting a blood clot from the Astrazeneca vaccine for each age group, compared to the benefits of getting the shot

Government experts did: modeling (above) to demonstrate the risk of getting a blood clot from the Astrazeneca vaccine for each age group, compared to the benefits of getting the shot

.